Results 41 to 50 of about 3,651 (158)

Gemtuzumab Ozogamicina: uma opção no tratamento de Leucemia mielóide aguda CD33+ Gemtuzumab Ozogamicin: an option in the treatment of acute myeloid leukemia CD33+

Revista Brasileira de Hematologia e Hemoterapia, 2004
Gemtuzumab Ozogamicina (GO) é um derivado semi-sintético de caliqueamicina, um antibiótico citotóxico ligado a um anticorpo monoclonal direcionado contra antígeno CD33 presente nos mieloblastos leucêmicos.
Celso M. Massumoto, Ronald F. Pinheiro, Edilson D. Pinheiro Júnior, Otávio C. Baiocchi, Adelson Alves   +4 more
doaj   +1 more source

Leucemia linfocítica crónica

Lux Médica, 2013
La Leucemia linfocítica crónica (LLC) es una neoplasia maligna que afecta a pacientes de mediana edad y ancianos, se caracteriza por la proliferación de linfocitos morfológicamente maduros pero inmunológicamente inmaduros y se manifiesta por su acumulación progresiva en la sangre, médula ósea y tejido linfático. Aunque es incurable, su evolución, en la
Jorge Omar Arias-Segura, José Mauricio Valero-González   +1 more
openaire   +2 more sources

Advancing Mantle Cell Lymphoma Risk Assessment: Navigating a Moving Target

Hematological Oncology, Volume 43, Issue S2, June 2025.
ABSTRACT Mantle cell lymphoma (MCL) is a B‐cell malignancy characterized by t(11;14)(q13;q32) translocation and heterogeneous clinical behavior. Advances in risk stratification enabled the distinction of conventional MCL (cMCL) from non‐nodal MCL (nnMCL) subtypes, which presents with distinct biological and clinical features.
Simone Ferrero, Simone Ragaini
wiley   +1 more source

Ver de Fora para Dentro: Um Caso de Leucemia Cutis no Contexto de Leucemia Linfoide Crónica

Gazeta Médica
A leucemia linfoide crónica é a leucemia mais comum nos países ocidentais, manifestando-se em média aos 70 anos. A sua etiologia não é conhecida, mas pensa-se que os fatores genéticos e ambientais poderão ter influência.
Mariana Assis Rocha, Ermelindo Tavares
doaj   +4 more sources

Enhanced Disease Detection of Hairy Cell Leukaemia Through Next‐Generation Sequencing Based BRAFV600E and Phased Variant Analysis

eJHaem, Volume 6, Issue 3, June 2025.
ABSTRACT Introduction Longitudinal disease assessment by molecular techniques is not routine in hairy cell leukaemia (HCL). Combining BRAFV600E and other genomic targets through next‐generation sequencing (NGS) with phased variant analysis is a novel approach for disease detection in this setting.
Simon Wu, Tamia Nguyen, Imogen Caldwell, Sally Hunter, Sushmitha Kannan, Camille Santos, Yan Zhuang Yap, Clarissa Wilson, Mayani Rawicki, Constantine S. Tam, Rachel Koldej, David Ritchie, Piers Blombery   +12 more
wiley   +1 more source

Impact of neighborhood archetypes on overall mortality among young patients with acute leukemia in California

Cancer, Volume 131, Issue 9, 1 May 2025.
Abstract Introduction Residence in lower socioeconomic neighborhoods is associated with lower survival in children, adolescents, and young adults with leukemia. We sought to evaluate the impact of neighborhood archetypes on acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) survival.
Lena E. Winestone, Juan Yang, Tanushree Banerjee, Meera Sangaramoorthy, Justine Kahn, Renata Abrahão, Theresa H. Keegan, Iona Cheng, Scarlett Lin Gomez, Salma Shariff‐Marco   +9 more
wiley   +1 more source

Factors associated with mortality in pediatric pa- tients with acute lymphoblastic leukemia and neu- tropenic enterocolitis treated for in the Intensive Care Unit

Acta Pediátrica de México, 2014
Background: Neutropenic enterocolitis is a complication manifested in cancer patients with neutropenia usually with absolute neutrophils counts of less than 500 cells/mm3.
Mireya Muñoz-Ramírez, Horacio Márquez-Gon- zález, Patricia Zárate-Castañón   +2 more
doaj   +1 more source

CHIC: A machine learning framework for inferring the presence of high‐risk clonal hematopoiesis using complete blood count data from 431,531 UK Biobank participants

HemaSphere, Volume 9, Issue 7, July 2025.
William G. Dunn, Isabella Withnell, Muxin Gu, Pedro Quiros, Sruthi Cheloor Kovilakam, Ludovica Marando, Sean Wen, Margarete A. Fabre, Irina Mohorianu, Dragana Vuckovic, George S. Vassiliou   +10 more
wiley   +1 more source

Leucemia mielóide crônica e síndrome de hiper-viscosidade: relato de caso Chronicle myeloid leukemia and hiperviscosity syndrome: case report

Revista Brasileira de Terapia Intensiva, 2008
JUSTIFICATIVA E OBJETIVOS: A hiperleucocitose (> 100 x 10(9)/L) em leucemia mielóide crônica não é uma apresentação comum e pode determinar manifestações clínicas de hiper-viscosidade.
Juliana Amâncio, Gisele Scuro, Fernanda Martins Gazoni, Hélio Penna Guimarães, Letícia Sandre Vendrame, Renato Delascio Lopes, Antônio Carlos Lopes   +6 more
doaj   +1 more source

Características clínicas y epidemiológicas en pacientes afectos de leucemia

Universidad Médica Pinareña, 2014
Introducción: el cáncer constituye uno de los padecimientos más temidos en el mundo, más que una estadística, una realidad: una enfermedad crónica y silenciosa que amenaza la vida.
Claudia Cabrera Morales, Marielys Pacheco Mosquera, César Valdés Sojo   +2 more
doaj